HKEX Stock Code: 01093English|繁體|简体

Highlight - 1Q2023

Revenue
RMB8,053mn, +2.3%
Underlying profit attributable to shareholders
RMB1,545mn, +0.1%
Profit attributable to shareholders
RMB1,429mn, +1.7%
Basic earnings per share
RMB11.99 cents, +1.7%

Key Products

Finished drugs
Bulk drugs
© Copyright 2023 CSPC Pharmaceutical Group Limited. All Rights Reserved.